Carlyle (CG) EBITDA (2011 - 2026)

Carlyle's EBITDA history runs 16 years deep, the most recent figure standing at -$140.4 million for Q1 2026.

• On a quarterly basis, EBITDA fell 169.23% year-over-year to -$140.4 million in Q1 2026; TTM through Mar 2026 was $949.9 million, a 45.2% decrease from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 192.74% from the prior year.
• EBITDA eased to -$140.4 million in Q1 2026 per CG's latest filing, from $500.1 million in the prior quarter.
• Across five years, EBITDA topped out at $903.2 million in Q3 2024 and bottomed at -$810.7 million in Q4 2023.
• The 5-year median for EBITDA is $280.8 million (2023), against an average of $274.0 million.
• Across the five-year window, EBITDA slumped 547.9% in 2023 and surged 545.63% in 2024, its largest moves.
• Year by year, EBITDA stood at $181.0 million in 2022, then slumped by 547.9% to -$810.7 million in 2023, then surged by 136.38% to $294.9 million in 2024, then jumped by 69.58% to $500.1 million in 2025, then plunged by 128.07% to -$140.4 million in 2026.
• Per Business Quant, the three latest CG EBITDA figures stand at -$140.4 million (Q1 2026), $500.1 million (Q4 2025), and $117.7 million (Q3 2025).